Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
133.00    1.40 (1.06%)
Bid:
132.70
Ask:
133.20
Spread: 0.50 (0.377%)
Market Cap: £336.34m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Directorate Change

1 Oct 2019 10:00

RNS Number : 2141O
Marshalls PLC
01 October 2019
 

1 October 2019 LEI: 213800S21IFC367J5V62

 

Directorate Change

 

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Marshalls plc announces its intention to appoint Angela Bromfield to the Board as an additional Non-Executive Director. Angela's appointment will take effect on 1 October 2019.

 

Vanda Murray OBE, Chair of the Board, commented: "The Board is delighted that Angela will be joining Marshalls plc as a Non-Executive Director. Given the planned retirement of Non-Executive Director Tim Pile in 2020, the timing of her appointment is designed to provide continuity and allow for knowledge transfer. Angela has an excellent track record of delivering growth, both in her executive and non-executive roles, as well as relevant sector experience and experience of strategy, marketing and e-commerce. She will be a valuable addition to the Board."

 

 

Enquiries:

Martyn Coffey

Chief Executive

Marshalls plc

++44 (0)1422 314777

Jack Clarke

Finance Director

Marshalls plc

++44 (0)1422 314777

Andrew Jaques/Robert Collett-Creedy

 

MHP Communications

++44 (0)20 312 88 540

 

Biographical Notes

Angela Bromfield is an experienced business strategist with a broad-based career in manufacturing, distribution, construction and infrastructure. She has held executive leadership positions with listed companies ICI, Premier Farnell and Anglo American, having been MD of Tarmac's National Contracting business, as well as being responsible for their UK e-business strategy, following which she joined Morgan Sindall plc as Executive Director, Strategy, Marketing and Communications from 2008 to 2013. She is also an experienced non-executive director; she currently serves on the Boards of Harworth Group PLC (non-executive director and member of Audit and Remuneration Committees), Zotefoams PLC (chair of the Remuneration Committee and member of Audit Committee), Churchill China PLC (an AIM listed company, where she chairs the Remuneration Committee and is a member of the Audit Committee) and Newton Green Consulting Limited. She holds an MBA from Warwick University and a degree in Chemistry.

 

Angela Bromfield is independent for the purposes of the UK Corporate Governance Code. Her recruitment follows a formal, rigorous and objective selection process led by the Nomination Committee with the help of external consultants Inzito. This announcement includes the information required by Listing Rules 9.6.11 to 9.6.13, and there is no information to report under Listing Rule 9.6.13R (2) - (6) inclusive.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUROVRKVAKOAR
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.